Country: United States
Language: English
Source: NLM (National Library of Medicine)
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG), SENNOSIDES A AND B (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN)
DIRECTRX
ORAL
OTC DRUG
stool softner, laxative Uses: Relieves occasional constipation (irregularity); generally causes bowel movement in 6-12 hours
OTC monograph not final
DOCUSATE SENNOSIDES- DOCUSATE SENNOSIDES TABLET, FILM COATED DIRECTRX REFERENCE LABEL SET ID: 835A2CD4-4801-3E40-E053-2A91AA0ABFEA _Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they_ _comply with applicable regulations and policies. FDA has not evaluated whether this product complies._ ---------- DOCUSATE SENNOSIDES Each Tablet contains: Docustate sodium 50 mg Sennosides 8.6 mg INACTIVE INGREDIENTS: carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, d-c yellow#10 aluminum lake fd&c yelow#6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, titanium dioxide stool softner, laxative Directions: Take preferably at bedtime or as directed by a doctor. If you do not have a comfortable bowel movement by the second day, increase dose by one tablet (not to exceed maximum dosage) or decrease dose until you are comfortable. Adults and children 12 years and over - starting dosage: 2 tablets once a day maximum dosage: 4 tablets twice a day Children 6 to under 12 years - starting dosage: 1 tablet once a day maximum dosage: 2 tablets twice a day Children to2 to under 6 years - starting dosage: 1/2 tablet once a day maximum dosage: 1 tablet twice a day Children under 2 years - Ask a doctor Uses: Relieves occasional constipation (irregularity); generally causes bowel movement in 6-12 hours WARNINGS: Do not use this product If you are presently taking mineral oil, unless directed by a doctor Laxative products for longer than 1 week unless directed by a doctor keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. DOCUSATE SENNOSIDES docusate sennosides tablet, film coated PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:6 19 19 -771(NDC:49 48 3-0 8 1) ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH DO CUSATE S Read the complete document